Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX-IL8 in Chronic Bronchitis and COPD
NCT00035828Phase 2Completed
- Sponsor
- Abgenix
- Start
- Dec 2001
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ABX-IL8 in chronic obstructive pulmonary disease (COPD), sponsored by Abgenix. Started Dec 2001; status: completed.
02
Drugs
ABX-IL8
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00035828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035828.